首页|Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats

Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats

扫码查看
AIM:To investigate the preventive effect of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) on bile duct ligation (BDL)-induced liver fibrosis in rats.METHODS:Liver fibrosis in rats was induced by BDL and AcSDKP was infused subcutaneously for 2 wk via a osmotic minipump (Alzet 2ML4) immediately after BDL operation.After scarifying,serum and liver specimens were collected.Hematoxylin and eosin staining,Sirius red staining,enzyme linked immunosorbent assay,Western blot or real-time polymerase chain reaction were used to determinate liver functions,histological alterations,collagen deposition,mRNA expression of markers for fibroblasts,transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7).RESULTS:When compared to model rats,chronic exogenous AcSDKP infusion suppressed profibrogenic TGF-β1 signaling,α-smooth muscle actin positivity (α-SMA),fibroblast specific protein-1 (FSP-1) staining and collagen gene expression.Col Ⅰ,Col Ⅲ,matrix metalloproteinase-2,tissue inhibitors of metalloproteinase-1 and tissue inhibitors of metalloproteinase-2 mRNA expressions were all significantly downregulated by AcSDKP infusion (2.02 ± 1.10 vs 14.16 ± 6.50,2.02 ± 0.45 vs 10.00 ± 3.35,2.91 ± 0.30 vs 7.83 ± 1.10,4.64 ± 1.25 vs 18.52 ± 7.61,0.46 ± 0.16 vs 0.34 ± 0.12,respectively,P < 0.05).Chronic exogenous AcSDKP infusion attenuated BDL-induced liver injury,inflammation and fibrosis.BDL caused a remarkable increase in alanine transaminase,aspartate transaminase,total bilirubin,and prothrombin time,all of which were reduced by AcSDKP infusion.Mast cells,collagen accumulation,α-SMA,TGF-β1,FSP-1 and BMP-7 increased.The histological appearance of liver specimens was also improved.CONCLUSION:Infusion of exogenous AcSDKP attenuated BDL-induced fibrosis in the rat liver.Preservation of AcSDKP may be a useful therapeutic approach in the management of liver fibrosis.

N-acetyl-seryl-aspartyl-lysyl-prolineLiver fibrosisTransformating growth factor-β1α-smooth mucle actinBone morphological protein-7Fibroblast specific protein-1Epithelial-mesenchymal transition

Lei Zhang、Lei-Ming Xu、Yuan-Wen Chen、Qian-Wen Ni、Min Zhou、Chun-Ying Qu、Yi Zhang

展开 >

Digestive Endoscopic Diagnosis and Treatment Center, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092,China

国家自然科学基金国家自然科学基金and Shanghai Pujiang Program

3097126381170410 to Chen YW10PJ1407600 to Chen YW

2012

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子:1.001
ISSN:1007-9327
年,卷(期):2012.18(37)
  • 6
  • 26